Publication: Canakinumab in adults with steroid-refractory pyoderma gangrenosum
Canakinumab in adults with steroid-refractory pyoderma gangrenosum
Date
Date
Date
Citations
Kolios, A. G. A., Maul, J.-T., Meier, B., Kerl, K., Traidl-Hoffmann, C., Hertl, M., Zillikens, D., Röcken, M., Ring, J., Facchiano, A., Mondino, C., Yawalkar, N., Contassot, E., Navarini, A. A., & French, L. E. (2015). Canakinumab in adults with steroid-refractory pyoderma gangrenosum. British Journal of Dermatology, 173(5), 1216–1223. https://doi.org/10.1111/bjd.14037
Abstract
Abstract
Abstract
Background: Pyoderma gangrenosum (PG) is a rare, neutrophilic, ulcerative skin disease that is difficult to treat, especially when unresponsive to steroids. Objectives: To determine whether canakinumab is an effective and safe treatment in PG. Methods: Five adult patients with clinically and histologically confirmed steroid-refractory PG were enrolled in this prospective open-label study. They received canakinumab 150 mg subcutaneously at week 0 with an optional 150 mg at week 2 in case of an inadequate response [Physician's Global As
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page Range
Page Range
Page Range
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Downloads
Views
Citations
Kolios, A. G. A., Maul, J.-T., Meier, B., Kerl, K., Traidl-Hoffmann, C., Hertl, M., Zillikens, D., Röcken, M., Ring, J., Facchiano, A., Mondino, C., Yawalkar, N., Contassot, E., Navarini, A. A., & French, L. E. (2015). Canakinumab in adults with steroid-refractory pyoderma gangrenosum. British Journal of Dermatology, 173(5), 1216–1223. https://doi.org/10.1111/bjd.14037